Rytary capsules — Medica
post-encephalitic parkinsonism
Preferred products
- generic carbidopa-levodopa tablets
- generic carbidopa-levodopa extended-release tablets
Initial criteria
- Patient has tried one Step 1 Product (generic carbidopa-levodopa tablets or generic carbidopa-levodopa extended-release tablets) OR a trial of Sinemet also satisfies the requirement
- OR patient is currently taking Crexont capsules or Rytary capsules
Reauthorization criteria
- Patient is currently taking Crexont capsules or Rytary capsules
Approval duration
1 year